Abirtega 250 mg/1
Abiraterone acetate · TABLET · CivicaScript, LLC
No Recall History
Plain English
Abirtega is a tablet containing abiraterone acetate at 250 mg/1, taken oral. Manufactured by CivicaScript, LLC.
Key Facts
- Brand Name
- Abirtega
- Generic Name
- Abiraterone acetate
- NDC Code (Product)
82249-011- Manufacturer
- CivicaScript, LLC
- Strength
- 250 mg/1
- Dosage Form
- TABLET
- Route
- ORAL, ORAL
- Marketing Status
- Application #
- ANDA208339
- Marketing Start
- 11/23/2018
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
death631 reports
fatigue451 reports
hot flush262 reports
asthenia256 reports
anaemia233 reports
hypokalaemia231 reports
diarrhoea209 reports
prostatic specific antigen increased207 reports
pneumonia201 reports
hypertension200 reports
Frequently Asked Questions
What is Abirtega used for?
Abirtega contains Abiraterone acetate. It is a tablet taken oral. Consult your doctor for specific uses.
Is Abirtega a controlled substance?
Abirtega is not classified as a controlled substance by the DEA.
What is the generic name for Abirtega?
The generic name for Abirtega is Abiraterone acetate. There are 12 other brand versions of Abiraterone acetate.
What is the NDC code for Abirtega 250 mg/1?
The NDC (National Drug Code) for Abirtega 250 mg/1 is 82249-011, listed by CivicaScript, LLC.
Other Abiraterone Brands
See all →- Abiraterone250 mg/182249-010
- Zytiga250 mg/157894-150
- Abiraterone acetate500 mg/171921-177
- Abiraterone Acetate125 mg/151407-503
- abiraterone acetate500 mg/160505-4764
- Abiraterone250 mg/172205-030
- Abiraterone Acetate250 mg/175907-224
- Abiraterone Acetate500 mg/182293-002
- Abiraterone500 mg/168001-673
- abiraterone acetate250 mg/172603-110
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)